CD8A and neoplasm: To determine whether the increase in CD8+ tumor-infiltrating lymphocytes (TILs) resulted from local proliferation or tumor infiltration, we depleted Tregs followed by daily FTY720 administration to block T cell trafficking, and quantified CD8+ TILs 5 days later.